(70 days)
No
The device description and performance studies focus on the physical characteristics and chemical analysis capabilities of blood collection tubes, with no mention of AI or ML.
No
The device is described as a collection tube for blood specimens for chemistry determinations, not for treating a disease or condition.
No
This device is a microcollection tube used to collect, transport, and store blood specimens for chemistry determinations. It does not perform diagnostic functions itself.
No
The device description clearly states it is a physical microcollection tube made of polypropylene and polyethylene, not software.
Based on the provided information, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states that the tubes are for collecting, transporting, and storing blood specimens "for chemistry determinations". Chemistry determinations are laboratory tests performed on biological samples (in this case, blood) to diagnose or monitor medical conditions. This aligns directly with the definition of an in vitro diagnostic device, which is used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes.
- Device Description: The device is a microcollection tube designed to hold blood specimens for these laboratory tests.
- Performance Studies: The performance studies describe testing the tubes' performance in relation to chemistry analytes measured on a chemistry analyzer. This further reinforces its role in the diagnostic process.
While the document doesn't explicitly state "In Vitro Diagnostic Device," the intended use and the context of its application in chemistry determinations clearly place it within the scope of IVDs.
N/A
Intended Use / Indications for Use
The MICROTAINER® Brand Chemistry Tubes with MICROGARD™ Closure are intended to collect, transport, and store skin puncture blood specimens for chemistry determinations requiring serum or heparinized plasma.
Product codes
JKA
Device Description
The modified MICROTAINER® Brand Chemistry Tubes with MICROGARD™ Closure are non-sterile, single use microcollection tubes. They consist of a polypropylene reservoir with an integral blood collector component, a skirted polyethylene closure with a recessed plug that reduces user exposure to blood.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical testing was done to compare the performance of the predicate MICROTAINER® Brand Tube, with the principal device, the modified MICROTAINER® Brand Tube with MICROGARD™ Closure.
The first part of the study evaluated the tubes for hemolysis and clotting. The study concluded that the principal device, the modified MICROTAINER® Brand Tube with MICROGARD™ Closure (evaluation tube), demonstrated equivalent or better performance compared to the predicate device, the MICROTAINER® Brand Tube (control tube). The study showed no clotting in any evaluation tube or control tube, and trace hemolysis in only one control tube.
The second part of the study compared the performance of the evaluation tube to a control tube using the Johnson and Johnson Vitros 250 Chemistry Analyzer to measure an array of chemistry analytes in plasma. Results from this study concluded that the principal device, the modified MICROTAINER® Brand Tube with MICROGARD™ Closure, demonstrated equivalent results to the predicate device, the MICROTAINER® Brand Tube for most of the analytes tested. The predicate device demonstrated a positive bias for several analytes, however the bias was not considered clinically significant. The final report can be referenced in Appendix A of this submission.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1675 Blood specimen collection device.
(a)
Identification. A blood specimen collection device is a device intended for medical purposes to collect and to handle blood specimens and to separate serum from nonserum (cellular) components prior to further testing. This generic type device may include blood collection tubes, vials, systems, serum separators, blood collection trays, or vacuum sample tubes.(b)
Classification. Class II.
0
I. 510(K) SUMMARY OF SAFETY AND EFFECTIVENESS
510(k) Summary Of Safety and Effectiveness
I. General Information
This Summary of Safety and Effectiveness information is being submitted in accordance with the requirements of the SMDA of 1990 and 21 § 807.92
Establishment:
| • | Address: | Becton Dickinson VACUTAINER Systems
1 Becton Drive
Franklin Lakes, NJ 07417-1885 |
|--------|------------------------|---------------------------------------------------------------------------------------------------------------|
| • | Registration Number: | 2243072 |
| • | Contact Person: | Andrea Hroncich
Senior Regulatory Affairs Associate
Telephone no.: 201-847-6173
Fax No. 201-847-4858 |
| • | Date of Summary: | May 18, 1999 |
| Device | | |
| • | Trade Name: | MICROTAINER® Brand Chemistry
Tubes with MICROGARD™ Closure |
| • | Classification Name: | Tubes, Vials, Systems, Serum Separators,
Blood Collection |
| • | Classification: | Class II |
| • | Performance Standards: | None Established under 514 of the |
- under 514 erformance Standards Food, Drug and Cosmetic Act
1
II. Safety and Effectiveness Information Supporting Substantial Equivalence
Substantial Equivalence Declaration:
The term "Substantial Equivalence" as used in this 510(k) Premarket Notification is limited to the definition of Substantial Equivalence found in the Federal Food, Drug, and Cosmetic Act, as amended and as applied under 21 CFR § 807, Subpart E, under which a device can be marketed without pre-market approval or reclassification. A determination of substantial equivalency under this notification is not intended to have ary bearing whatsoever on the resolution of patent infringement suits or any other No statements related to, or in support of, substantial equivalence Datent matters. herein shall be construed as an admission against interest under the US Patent Laws or their application by the courts.
-
· Device Description
The modified MICROTAINER® Brand Chemistry Tubes with MICROGARD™ Closure are non-sterile, single use microcollection tubes. They consist of a polypropylene reservoir with an integral blood collector component, a skirted polyethylene closure with a recessed plug that reduces user exposure to blood. -
Intended Use
The MICROTAINER® Brand Chemistry Tubes with MICROGARD™ Closure are intended to collect, transport, and store skin puncture blood specimens for chemistry determinations requiring serum or heparinized plasma. -
· Synopsis of Performance Study Results
Clinical testing was done to compare the performance of the predicate MICROTAINER® Brand Tube, with the principal device, the modified MICROTAINER® Brand Tube with MICROGARD™ Closure.
The first part of the study evaluated the tubes for hemolysis and clotting. The study concluded that the principal device, the modified MICROTAINER® Brand Tube with MICROGARD™ Closure (evaluation tube), demonstrated equivalent or better performance compared to the predicate device, the MICROTAINER® Brand Tube (control tube). The study showed no clotting in any evaluation tube or control tube, and trace hemolysis in only one control tube.
The second part of the study compared the performance of the evaluation tube to a control tube using the Johnson and Johnson Vitros 250 Chemistry Analyzer to measure an array of chemistry analytes in plasma. Results from this study concluded that the principal device, the modified MICROTAINER® Brand Tube with MICROGARD™ Closure, demonstrated equivalent results to the predicate device, the MICROTAINER® Brand Tube for most of the analytes tested. The predicate device demonstrated a positive bias for several analytes, however the bias was not considered clinically significant. The final report can be referenced in Appendix A of this submission.
In conclusion, the data supports a determination of equivalent performance between the modified MICROTAINER® Brand Tube with MICROGARD™ Closure as presented in this submission and the currently marketed predicate device.
2
III. Predicate Device Summary Table
- · Substantial Equivalence
Based on comparison of the intended use, technology/ principles of operation, materials and performance in the first case, and design and materials in the second, the MICROTAINER® Brand Chemistry tubes can be shown to be substantially equivalent to the commercially available predicate devices indicated in the table below. The predicate devices, K number, and clearance dates are also identified in the table.
| Manufacturer | Predicate Device | K-Number | Clearance Date |
|---|---|---|---|
| Becton Dickinson | |||
| VACUTAINER | |||
| Systems | MICROTAINER® | ||
| Brand Tubes | K771370 | 8/3/77 | |
| Becton Dickinson | |||
| VACUTAINER | |||
| Systems | MICROTAINER® | ||
| Brand EDTA Tube | |||
| with MICROGARD™ | |||
| Closure | K931368/A | 9/28/93 |
Amarea Homici
Andrea Hroncich Regulatory Affairs Associate Becton Dickinson VACUTAINER Systems Becton Dickinson and Company
May 18, 1999
Date
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three wavy lines representing its body.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
JUL 28 1999
Ms. Andrea Hroncich Regulatory Affairs Associate Beckton Dickinson VACUTAINER Systems 1 Becton Drive Franklin Lakes, New Jersey 07417-1885
Re: K991702
Trade Name: MICROTAINER® Brand Chemistry tubes with MICROGARD™ Closure Regulatory Class: II Product Code: JKA Dated: May 18, 1999 Received: May 19, 1999
Dear Ms. Hroncich:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D, M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
B. INDICATIONS FOR USE
510(k) Number (if known): K991702
Device Name: MICROTAINER® Brand Chemistry tubes with MICROGARD™ Closure
Indications for Use:
The MICROTAINER® Brand Chemistry tubes with MICROGARD™ Closure are intended to collect, The MICKOTAINER® Bland Chemisu y tuoss while MIGHONG Corporations requiring serum or heparinized plasma.
Jean Copper
(Divisior Sign-Off)
Division Clinical Laboratory Devices
510(k) Number K991702
(Please do not Write below this line-continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Or
Prescription Use _
Over-the-Counter Use_
(Per 21 CFR § 801.109)
(Optional format 1-2-96)